Catalyst Wire Dossier Catalyst Wire Dossier

Sorafenib (Nexavar)

Sorafenib · Bayer
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for Sorafenib (Nexavar), covering 2009-02-24 to 2025-12-31. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Sorafenib in Previously Treated Advanced Hepatocellular Carcinoma: SOPT Study [Phase 2]

See pricing